Pharmacokinetics and Tolerability of Nasal Versus Intravenous Midazolam in Healthy Dutch Volunteers: A Single-Dose, Randomized-Sequence, Open-Label, 2-Period Crossover Pilot Study

Nicole M. L. Veldhorst-Janssen*, Audrey A. A. Fiddelers, Paul-Hugo M. van der Kuy, H. Maurice S. Theunissen, Marc C. T. F. M. de Krom, Cees Neef, Marco A. E. Marcus

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2022-2028
JournalClinical Therapeutics
Issue number12
Publication statusPublished - Dec 2011


  • intranasal
  • midazolam
  • pharmacokinetics
  • pilot study

Cite this